並木 徳之
Faculty

学部・大学院

並木 徳之

所属 薬学部 薬学科 教授
最終学歴 東京薬科大学薬学部
現在所属している学会 日本薬剤学会、日本薬学会、日本医療薬学会、FIP
学士・修士・博士 博士(薬学)
所有資格 薬剤師免許、博士(薬学)、普通第一種圧力容器取扱作業主任者免許、認定薬剤師、指導薬剤師
研究の分野 医療系薬学
主な研究項目 製剤学、薬剤学、臨床薬学
主な研究業績 In vitro transdermal permeation and in vivo transdermal absorption of domperidone cream formulations compounded from tablets as a hospital formulation.(査読付き)/PHARMAZIE., 76: 2-5 /共著/2021. 01/PHARMAZIE/共著/2021.01
Morphological evaluation of low-dose midazolam granules by laser Raman microscopy(査読付き)/ Int. J. Pharm. , 590, 119940/共著/2020. 09/Int. J. Pharm./共著/2020.09
Sustained impact of community pharmacist-led intensive education on the management of serum phosphate levels in patients receiving haemodialysis(査読付き)/ International Journal of Clinical Pharmacy, 68, 981-988/共著/ 2020. 08/International Journal of Clinical Pharmacy/共著/2020.08
Evaluation of weight variation in mini-tablets manufactured by a multiple-tip tool(査読付き)/Chem. Pharm. Bull. Vol.68, pp.981-988/共著/ 2020. 07/Chem. Pharm. Bull./共著/2020.07
Evaluation of in vitro and in vivo transdermal absorption of solifenacin succinate(査読付き)/Chem. Pharm. Bull., Vol.67, pp.1225-1231/共著/2019. 11/Chem. Pharm. Bull./2019.11
An effective polyvinyl alcohol for the solubilization of poorly water-soluble drugs in solid dispersion formulations( 査読付き)/Journal of Drug Delivery Science and Technology, 55, 101401/共著/2019. 11/Journal of Drug Delivery Science and Technology/共著/2019.11
The prediction of the area under the curve and clearance of midazolam from single-point plasma concentration and urinary excretion in healthy volunteers/(査読付き)/Bio. Pharm. Bull., Vol.42, pp.1590-1595/Bio. Pharm. Bull./共著/2019.09
Ease of taking and palatability of fixed-dose orally disintegrating mitiglinide/voglibose tablets(査読付き)/Chem. Pharm. Bull., Vol.67, pp.540-545/共著/2019. 06/Chem. Pharm. Bull./共著/2019.06
Preparation of cocoa powder-containing orally disintegrating tablets of rebamipide (rebamipide chocolet) and evaluation of their clinical palatability(査読付き)/Chem. Pharm. Bull., Vol.67, pp.1-9/Chem. Pharm. Bull./共著/2019.01
In vivo drug dissolution in human oral cavity from orally disintegrating tablet and comparability with in vitro testing(査読付き)/Chem. Pharm. Bull., Vol.66, pp.999-1005/共著/2018. 10/Chem. Pharm. Bull./共著/2018.10
Palatability and preference of gummi formulation with various pharmaceutical characteristics(査読付き)/Chem. Pharm. Bull., Vol.66, pp.452-457/共著/2018. 04   /Chem. Pharm. Bull./共著/2018.04
Changes in gefitinib, erlotinib and osimertinib pharmacokinetics under various gastric pH levels following oral administration of omeprazole and vonoprazan in rats(査読付き)/Xenobiotica, DOI: 10. 1080/00498254. 1396379/共著/2017. 10/Xenobiotica/共著/2017.10
Citric acid suppresses the bitter taste of olopatadine hydrochloride orally disintegrating tablets (査読付き)/Bio. Pharm. Bull., Vol.40,pp. 451-457.2017. 04/Bio. Pharm. Bull./共著/2017.04
Orally sustained-release suspension based on a lauryl sulfate salt/complex(査読付き)/Int. J. Pharm., 515, 677-683/共著/2016. 10/Int. J. Pharm./共著/2016.10
Oral sustained release of a hydrophilic drug using the lauryl sulfate salt/complex(査読付き)/Chem. Pharm. Bull., Vol.64, PP.1304-1309/共著/22016. 09/Chem. Pharm. Bull./共著/2016.09
The prediction of the palatability of orally disintegrating tablets by an electronic gustatory system(査読付き)/Int. J. Pharm., 493, 305-312/共著/2015. 07 /Int. J. Pharm./共著/2015.07
Development of gummi drugs of aripiprazole as hospital formulation(査読付き)/Chem. Pharm. Bull., Vol.63, pp.354-360/共著/2015. 05/Chem. Pharm. Bull./共著/2015.05
Preparation and evaluation of orally disintegrating tablets containing vitamin E as a model fat-soluble drug(査読付き)/Chem. Pharm. Bull., Vol.63, No.3, pp.156-163/共著/2015. 03/Chem. Pharm. Bull./共著/2015.03
Effect of granule properties on rough mouth feel and palatability of orally disintegrating tablets(査読付き)/Int. J. Pharm., 484, 156-162/共著/2015. 02/Int. J. Pharm./共著/2015.02
Preparation and evalution of highly drug-loaded fine globular granules using a multi-functional rotor processor(査読付き)/Chem. Pharm. Bull., Vol.63, pp.95-101/共著/2015. 02/Chem. Pharm. Bull./共著/2015.02
Combination effect of physical and gustatory taste masking for propiverine hydrochloride orally disintegrating tablets on palatability(査読付き)/Bio. Pharm., pp.17-22/共著/2015. 01/Bio. Pharm./共著/2015.01
In vitro and in vivo evaluation under finite conditions of a transdermal oil-in-water type emulsified formulation of propiverine hydrochloride(査読付き)/Bio. Pharm. Bull., Vol.37, pp.1661-1667/共著//Bio. Pharm. Bull./共著/2014.10
Preparation and characterization of high-content aripiprazole-loaded core-shell structure microsphre for long-release injectable formulation(査読付き)/Chem. Pharm. Bull., Vol.62, pp.654-66/共著/2014. 07/Chem. Pharm. Bull./共著/2014.07
Clinical efficacy and pharmacokinetics of levothyroxine suppository in patiens with hypothyroidism(査読付き)/Bio. Pharm. Bull., Vol.37, pp,666-670/共著/2014. 04/Bio. Pharm. Bull./共著/2014.04
Simultaneous LC-MS/MS analysis of the plasma concentrations of a cocktail of 5 cytochrome P450 substrate durgs and their metabolites(査読付き)/Bio. Pharm. Bull., Vol.37, pp18-25/共著/2014. 01/Bio. Pharm. Bull./共著/2014.01
Comparison of inhibitory duration of grapefurit juice on organic anion-transporting polypeptide and cytochrome P450 3A4(査読付き)/Bio. Pharm. Bull., Vol.36, pp.1936-1941/共著/2013. 12/Bio. Pharm. Bull./共著/2013.12
Clinical disintegration time of orally disintegrating tablets clinically available in Japan in healty volunteers(査読付き)/Bio. Pharm. Bull., Vol.36, pp.1488-1493/共著/2013. 09/Bio. Pharm. Bull./共著/2013.09
Chronological effects of rifampicin discontinuation on cytochrome P450 activity in healty japanese volunteers, using the cocktail method(査読付き)/Clinical Pharmacology & Therapeutics, Vol.96, pp. 702-708/共著/2013. 09/Clinical Pharmacology & Therapeutics/共著/2013.09
Pharmaceutical Development of a Parenteral Formulation of Conivaptan Hydrochloride(査読付き)/PDA J Pharm Sci Technol, 67:336-353 /共著/2013. 08/PDA J Pharm Sci Technol/共著/2013.08
Taste-masking effect of physical and organoleptic methods on peppermint-scented orally disintegrating tablet of famotidine based on suspension spray-coating method.(査読付き)/Chem. Pharm. Bull., Vol.60, pp.315-319/共著/2013. 03/Chem. Pharm. Bull./共著/2013.03
Reduction in the volume of water for ingesting orally disintegrating tablets of solifenacin (Vesicare® OD), and the clinical disintegration time of Vesicare® OD after unit-dose packaging(査読付き)/Int. J. Pharm., 446: 1-5/共著/2013. 03/Int. J. Pharm./共著/2013.03
Preparation and evalution of unpleasant taste-masked pioglitazone orally disintegrating tablets(査読付き)/Int. J. Pharm., 446: 160-165/共著/2013. 02/Int. J. Pharm./共著/2013.02
Effects of dosing interval on the pharmacokinetic and pharmacodynamic interactions between the oral adsorbent AST-120 and triazolam in humans(査読付き)/Eur J Clin Pharmacol., Vol.68, pp. 1605-1610/共著/2012. 10/Eur J Clin Pharmacol./共著/2012.10
Influence of Different Proton Pump Inhibitors on Activity of Cytochrome P450 Assessed by [13C]-Aminopyrine Breath Test.(査読付き)/J Clin Pharmacol., Vol.52, pp.432-439/共著/2012. 05/J Clin Pharmacol./共著/2012.05
Formulation Study for Orally Disintegrating Tablet Using Partly Pregelatinized Starch Binder(査読付き)/Chem. Pharm. Bull., Vol.59, pp.959-964/共著/2011. 08/Chem. Pharm. Bull./共著/2011.08
Onset of clinical effects and plasma concentration of fluvoxamine in japanese patients(査読付き)/Biol. Pharm. Bull., Vol.33, pp.1999-2002/共著/2010. 12/Biol. Pharm. Bull./共著/2010.12
Effect of cigarette smoking and cytochrome P450 2D6 genotype on fluvoxamine concentration in plasma of Japanese patients.(査読付き)/Biol. Pharm. Bull., Vol.33, pp.285-288/共著/2010. 02/Biol. Pharm. Bull./共著/2010.02
すべてがわかる口腔内崩壊錠ハンドブックー製剤技術・装置・添加剤偏/じほう社/共著/2020.02
医薬品製剤開発のための次世代微粒子コーティング技術/シーエムシー出版/共著/2012.12
すべてがわかる口腔内崩壊錠ハンドブック/じほう社/共著/2012.01
製剤化のサイエンス/じほう社/共著/2010.03
薬剤師による手術室の薬剤管理マニュアル/じほう社/共著/2008.10
臨床薬物治療学/アークメディア/共著/2000.04
主な担当授業科目名 製剤学、薬物治療学Ⅰ